RETROVIR

ViiV Healthcare Company🇺🇸 United States

FDA Page

Effective Date: Nov 13, 2024
Approval ID: 6df09f15-b102-431c-adde-d7aeef6f5d84
Products: 3 registered
Version: 29

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RETROVIR safely and effectively. See full prescribing information for RETROVIR.RETROVIR (zidovudine) capsules, for oral useRETROVIR (zidovudine) oral solutionRETROVIR (zidovudine) injection, for intravenous useInitial U.S. Approval: 1987

Quick Stats

Total Products3

Labelers2

Label Sections28

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.